Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 17588358)

Published in Curr Oncol Rep on July 01, 2007

Authors

Suzanne George1

Author Affiliations

1: Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. sgeorge2@partners.org